Nexavar 200 mg Tablet – Sorafenib for Advanced Kidney Cancer
Nexavar 200 mg Tablet contains Sorafenib 200 mg, a prescription targeted anticancer medicine used to treat patients with advanced renal cell carcinoma (RCC), a type of kidney cancer. It may also be prescribed for selected patients with unresectable liver cancer or progressive differentiated thyroid cancer that no longer responds to radioactive iodine treatment. Sorafenib belongs to a class of medicines known as multikinase inhibitors. It blocks certain proteins involved in the growth and multiplication of cancer cells. It also reduces the development of new blood vessels that supply the tumour, helping slow the progression of the disease. Nexavar 200 mg Tablet must be used only under the supervision of an oncologist experienced in anticancer treatment. The dosage, duration, treatment interruptions, and dose reductions depend on the patient’s condition, treatment response, and side effects.
Key Features
- Contains Sorafenib 200 mg: A targeted multikinase inhibitor.
- Used for Advanced Kidney Cancer: Indicated for advanced renal cell carcinoma.
- Targeted Anticancer Therapy: Blocks proteins involved in tumour-cell growth and blood-vessel formation.
- Oral Treatment: Supplied as a film-coated tablet for oral administration.
- Requires Regular Monitoring: Blood pressure, liver function, skin reactions, and treatment response should be monitored.
Active Ingredient
- Sorafenib 200 mg: A multikinase inhibitor that targets pathways involved in cancer-cell growth and tumour blood-vessel development.
Uses
- Treatment of advanced renal cell carcinoma, also known as advanced kidney cancer.
- Treatment of unresectable hepatocellular carcinoma.
- Treatment of locally recurrent or metastatic, progressive differentiated thyroid carcinoma that is resistant to radioactive iodine treatment.
How to Use
- Take Nexavar exactly as prescribed by your oncologist.
- The commonly recommended adult dosage is 400 mg, equivalent to two 200 mg tablets, twice daily unless the oncologist prescribes otherwise.
- Take the tablets without food, at least one hour before or two hours after a meal.
- Swallow the tablets whole with water.
- Do not crush, chew, split, or dissolve the tablets.
- Take each dose at approximately the same time every day.
- If you miss a dose, skip it and take the next dose at the usual scheduled time.
- Do not take a double dose to compensate for a missed dose.
- Do not change the dosage or stop treatment without consulting your oncologist.
Monitoring and Precautions
- Use only under the supervision of a qualified oncologist.
- Blood pressure should be checked regularly, particularly during the first six weeks of treatment.
- Liver-function tests and other laboratory investigations may be required during treatment.
- Inform your doctor if you have heart disease, high blood pressure, liver problems, bleeding disorders, kidney impairment, or an abnormal heart rhythm.
- Inform your healthcare provider before undergoing surgery, as sorafenib may affect wound healing.
- Tell your doctor about all prescription medicines, non-prescription medicines, vitamins, and herbal supplements you use.
- Inform your doctor if you take warfarin, rifampicin, neomycin, seizure medicines, or medicines that may affect heart rhythm.
- Pregnancy must be avoided during treatment because sorafenib may harm an unborn baby.
- Breastfeeding is not recommended during treatment and for the period advised after the final dose.
Warning
- Heart Problems: Sorafenib may cause reduced blood flow to the heart, heart attack, or heart failure.
- Bleeding: Treatment may increase the risk of serious or potentially fatal bleeding.
- High Blood Pressure: Blood pressure may increase, particularly during the early weeks of treatment.
- Hand-Foot Skin Reaction: Pain, redness, swelling, blistering, or peeling may develop on the palms or soles.
- Severe Skin Reactions: Rare but serious reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, may occur.
- Liver Injury: Sorafenib may cause hepatitis, liver failure, or abnormal liver function results.
- Gastrointestinal Perforation: Rarely, a hole may develop in the stomach or intestinal wall.
- Heart-Rhythm Changes: Sorafenib may prolong the QT interval in susceptible patients.
- Seek urgent medical attention for chest pain, breathing difficulty, severe bleeding, black stools, vomiting blood, severe abdominal pain, yellowing of the skin, fainting, or a widespread blistering rash.
Common Side Effects
- Diarrhoea.
- Fatigue or weakness.
- Hand-foot skin reaction.
- Skin rash or dryness.
- Hair thinning or hair loss.
- Reduced appetite and weight loss.
- Nausea or abdominal discomfort.
- High blood pressure.
- Mouth soreness.
- Muscle, joint, or bone pain.
Storage
- Store at controlled room temperature between 20°C and 25°C.
- Temporary temperature variations between 15°C and 30°C may be permitted according to the official product instructions.
- Store in a dry place and protect the tablets from moisture.
- Keep the tablets in their original packaging until use.
- Do not use the medicine after the expiry date printed on the packaging.
- Keep out of reach of children and pets.
FAQs
1. Nexavar 200 mg Tablet is prescribed for adults with advanced liver cancer, kidney cancer, or differentiated thyroid cancer. It should only be used under the supervision of an oncologist.
2. In some cases, Nexavar may be used alongside other cancer treatments, but only if your doctor recommends it. Do not combine it with any medication without medical advice.
3. Hair thinning or mild hair loss can occur during treatment. This side effect is usually manageable, but inform your doctor if it becomes severe.
4. Stay hydrated, eat a balanced diet, monitor your blood pressure, avoid smoking and excessive alcohol, and attend all scheduled follow-up appointments to help manage your treatment safely.
5. Nexavar may be used for an extended period as long as it remains effective and the side effects are manageable. Your doctor will decide how long your treatment should continue.
Legal Disclaimer: Nexavar 200 mg Tablet is a prescription anticancer medicine intended for use only under the supervision of a qualified oncologist. It can cause serious or life-threatening adverse effects and requires appropriate medical monitoring. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, treatment, or the official prescribing information supplied with the medicine.














Reviews
There are no reviews yet.